TCG Crossover Management »

AgomAb Therapeutics NV shares owned by TCG Crossover Management

Quarter-by-quarter ownership of AgomAb Therapeutics NV (AGMB) shares owned by TCG Crossover Management from 13F filings

Historical chart of TCG Crossover Management investment in AgomAb Therapeutics NV

Tip: Access up to 7 years of quarterly data

All positions including AgomAb Therapeutics NV held by TCG Crossover Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in AgomAb Therapeutics NV by TCG Crossover Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $22M 2.1M 10.49

More positions owned by TCG Crossover Management

Abivax Sa American Depositary Shares Adrs (ABVX)
Cg Oncology Comm (CGON)
Tango Therapeutics Comm (TNGX)
Cogent Biosciences Comm (COGT)
Centessa Pharmaceuticals Adrs
Dianthus Therapeutics Comm (DNTH)
Tyra Biosciences Comm (TYRA)
Immunovant Comm (IMVT)
Biocryst Pharmaceuticals Comm (BCRX)
Mirum Pharmaceuticals Comm (MIRM)
Vor Biopharma Comm (VOR)
Spyre Therapeutics Comm (SYRE)
Amylyx Pharmaceuticals Comm (AMLX)
Disc Medicine Comm (IRON)
Dyne Therapeutics Comm (DYN)

View all positions for TCG Crossover Management

Top funds holding AgomAb Therapeutics NV

EQT Fund Management S.a r.l.
Sanofi
Cormorant Asset Management
TCG Crossover Management
Federated Investors
Casdin Capital
Andera Partners
FMR
Nantahala Capital Management
Standard Life Aberdeen
Perceptive Advisors
Samsara BioCapital
Siren
LMR Partners
Seven Grand Managers

View all funds holding AgomAb Therapeutics NV